BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35333774)

  • 1. Local anesthetic levobupivacaine inhibits stemness of osteosarcoma cells by epigenetically repressing MAFB though reducing KAT5 expression.
    Wang Z; Song Y; Zhang H; Yang Y; Zhang S; Wang W
    Aging (Albany NY); 2022 Mar; 14(6):2793-2804. PubMed ID: 35333774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MAFB Promotes Cancer Stemness and Tumorigenesis in Osteosarcoma through a Sox9-Mediated Positive Feedback Loop.
    Chen Y; Wang T; Huang M; Liu Q; Hu C; Wang B; Han D; Chen C; Zhang J; Li Z; Liu C; Lei W; Chang Y; Wu M; Xiang D; Chen Y; Wang R; Huang W; Lei Z; Chu X
    Cancer Res; 2020 Jun; 80(12):2472-2483. PubMed ID: 32234710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketamine suppresses proliferation and induces ferroptosis and apoptosis of breast cancer cells by targeting KAT5/GPX4 axis.
    Li H; Liu W; Zhang X; Wu F; Sun D; Wang Z
    Biochem Biophys Res Commun; 2021 Dec; 585():111-116. PubMed ID: 34800882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circular RNA circPIP5K1A contributes to cancer stemness of osteosarcoma by miR-515-5p/YAP axis.
    Shi P; Li Y; Guo Q
    J Transl Med; 2021 Nov; 19(1):464. PubMed ID: 34774083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circular RNA circRHOT1 contributes to pathogenesis of non-small cell lung cancer by epigenetically enhancing C-MYC expression through recruiting KAT5.
    Ren X; Yu J; Guo L; Ma H
    Aging (Albany NY); 2021 Aug; 13(16):20372-20382. PubMed ID: 34406978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GREM1 overexpression inhibits proliferation, migration and angiogenesis of osteosarcoma.
    Gu Q; Luo Y; Chen C; Jiang D; Huang Q; Wang X
    Exp Cell Res; 2019 Nov; 384(1):111619. PubMed ID: 31525341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA HIF2PUT inhibited osteosarcoma stem cells proliferation, migration and invasion by regulating HIF2 expression.
    Zhao D; Wang S; Chu X; Han D
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1342-1348. PubMed ID: 30966832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the FOXM1-regulated long noncoding RNA TUG1 in osteosarcoma.
    Li Y; Zhang T; Zhang Y; Zhao X; Wang W
    Cancer Sci; 2018 Oct; 109(10):3093-3104. PubMed ID: 30099814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-223 targeting MAFB suppresses proliferation and migration of nasopharyngeal carcinoma cells.
    Yang W; Lan X; Li D; Li T; Lu S
    BMC Cancer; 2015 Jun; 15():461. PubMed ID: 26055874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circular RNA circMRPS35 regulates progression and autophagy in osteosarcoma cells by recruiting KAT6B to govern FOXO3.
    Jiang C; Jiang Z; Zhang X
    Anticancer Drugs; 2022 Aug; 33(7):607-613. PubMed ID: 35503036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-363 suppresses cell migration, invasion, and epithelial-mesenchymal transition of osteosarcoma by binding to NOB1.
    Zhang Y; Wang F; Wang L; Zhang Q
    World J Surg Oncol; 2020 May; 18(1):83. PubMed ID: 32357945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA‑487b‑3p inhibits osteosarcoma chemoresistance and metastasis by targeting ALDH1A3.
    Cheng M; Duan PG; Gao ZZ; Dai M
    Oncol Rep; 2020 Dec; 44(6):2691-2700. PubMed ID: 33125503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of miR‑95-3p inhibits growth of osteosarcoma by targeting HDGF.
    Liu X; Ma W; Ma J; Xiao L; Hao D
    Pathol Res Pract; 2019 Aug; 215(8):152492. PubMed ID: 31257090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF-β is associated with poor prognosis and promotes osteosarcoma progression
    Ma K; Zhang C; Li W
    Cell Cycle; 2020 Sep; 19(18):2327-2339. PubMed ID: 32804027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cinobufagin Suppresses The Characteristics Of Osteosarcoma Cancer Cells By Inhibiting The IL-6-OPN-STAT3 Pathway.
    Zhang C; Ma K; Li WY
    Drug Des Devel Ther; 2019; 13():4075-4090. PubMed ID: 31824138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic Profiling Identifies LIF as a Super-enhancer-Controlled Regulator of Stem Cell-like Properties in Osteosarcoma.
    Lu B; He Y; He J; Wang L; Liu Z; Yang J; Gao Z; Lu G; Zou C; Zhao W
    Mol Cancer Res; 2020 Jan; 18(1):57-67. PubMed ID: 31615908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
    Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
    Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of RBM10 induces osteosarcoma cell apoptosis and inhibits cell proliferation and migration.
    Han LP; Wang CP; Han SL
    Med Sci (Paris); 2018 Oct; 34 Focus issue F1():81-86. PubMed ID: 30403180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly-expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β-catenin and mTOR/HIF1α/VEGF signaling.
    Zhang Y; Cheng H; Li W; Wu H; Yang Y
    Int J Cancer; 2019 Aug; 145(4):1068-1082. PubMed ID: 30761524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The histone acetyltransferase HBO1 functions as a novel oncogenic gene in osteosarcoma.
    Gao YY; Ling ZY; Zhu YR; Shi C; Wang Y; Zhang XY; Zhang ZQ; Jiang Q; Chen MB; Yang S; Cao C
    Theranostics; 2021; 11(10):4599-4615. PubMed ID: 33754016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.